Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (February 2020) - Sardh, E.; Gouya, L.; Rees, D.C.; Stein, P.; Stölzel, U.; Aguilera Peiro, P.; Bissell, D.M.; Bonkovsky, H.L.; Keel, S.; Parker, C.; Phillips, J.D.; Silver, S.; et al.